Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy

Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy. The currently used markers to moni...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mediators Inflamm
Autors principals: Refaat, Bassem, Ashshi, Ahmed Mohamed, El-Shemi, Adel Galal, Azhar, Esam
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417604/
https://ncbi.nlm.nih.gov/pubmed/25969625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/287640
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars